BRAF and neoplasm: Since the mechanisms by which metabolic alterations interact with signaling downstream from mutated BRAF and KRAS have not been completely elucidated, the aim of our study was to investigate the impact of BRAFV600E and KRASG12V on tumor cell metabolism and signaling.